NFKB1 and endothelial dysfunction: Together, these findings suggest that HBM-EVs attenuate vascular inflammation by modulating NFκB–dependent signaling and may serve as a promising therapeutic strategy to mitigate obesity-related endothelial dysfunction.Oxidative stress is closely linked to inflammation and plays a critical role in endothelial dysfunction.